XML 37 R30.htm IDEA: XBRL DOCUMENT v3.24.3

Net Income/Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share

		For the Three Months Ended September 30,								For the Nine Months Ended September 30,
		2024				2023				2024				2023
(In thousands, except share and per share data)						(As Restated)								(As Restated)
Net income (loss)		$	76,971			$	(9,906	)		$	8,433			$	(86,438	)
Undistributed earnings allocated to participating securities			(22,542	)			—				(2,882	)			—
Net income (loss) attributable to common shares - basic			54,429				(9,906	)			5,551				(86,438	)
Allocated undistributed earnings allocated to participating securities			22,542				—				2,882				—
Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds, net of tax			(94,475	)			—				(69,519	)			—
Net loss attributable to common shares, basic		$	(17,504	)		$	(9,906	)		$	(61,086	)		$	(86,438	)
Basic weighted-average common shares outstanding			51,945,920				29,974,400				41,443,049				22,813,085
Potentially dilutive common shares:
Common stock warrants			3,532,422				—				1,663,697				—
Weighted-average number of common shares outstanding, diluted			55,478,342				29,974,400				43,106,746				22,813,085
Basic net income (loss) per common share		$	1.05			$	(0.33	)		$	0.13			$	(3.79	)
Diluted net loss per common share		$	(0.32	)		$	(0.33	)		$	(1.42	)		$	(3.79	)

Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive

The computation of diluted earnings per share excludes incentive stock options, restricted stock units, preferred stock and warrants that are anti-dilutive. The following table provides a summary as of September 30, 2024 and 2023 of common share equivalents that were excluded because their inclusion would have been anti-dilutive.

		For the Nine Months Ended September 30,
		2024				2023
Preferred Stock			6,361,567				6,361,567
Stock options outstanding and other equity awards			16,543,376				15,238,434
Common and preferred warrants outstanding			18,567,751				18,577,332
Total			41,472,694				40,177,333

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration